Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
This project focuses on validating a new potential cancer treatment that was designed using artificial intelligence at Carleton University. The student (Ruofan Wang) will travel to a partner laboratory in France to test this treatment on specific cancer cells that rely on a tumor-promoting protein called SMYD3. This physical visit is critical because the partner lab possesses unique cancer cell lines that are essential for proving the treatment works but are too fragile to be shipped to Canada. The project benefits both institutions by allowing the Canadian team to prove their AI-designed drug is effective in real biological systems, while providing the French team with a new tool to study cancer progression, strengthening a long-term international research partnership
Kyle Biggar
Université Grenoble Alpes
Life Sciences
Education
Carleton University
Globalink Research Award
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.
Mitacs is funded by the Government of Canada, the Government of Alberta, the Government of British Columbia, Research Manitoba, the Government of New Brunswick, the Government of Newfoundland and Labrador, the Government of Nova Scotia, the Government of Ontario, Innovation PEI, the Government of Quebec, the Government of Saskatchewan, and the Government of Yukon.